Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ENZ - ENZO BIOCHEM INC

Close
0.7091
-0.004   -0.606%

Share volume: 6,560
Last Updated: Thu 26 Dec 2024 08:18:29 PM CET

PREVIOUS CLOSE
CHG
CHG%
$0.71
0.00
-0.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.90%
1 Month
-30.11%
3 Months
-36.24%
6 Months
-32.69%
1 Year
-47.33%
2 Year
-44.51%
Key data
Stock price
$0.71
P/E Ratio 
1.31
DAY RANGE
$0.71 - $0.71
EPS 
$0.89
52 WEEK RANGE
$0.73 - $1.50
52 WEEK CHANGE
-$47.33
MARKET CAP 
58.662 M
YIELD 
N/A
SHARES OUTSTANDING 
51.458 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/10/2024
BETA 
0.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$421,026
AVERAGE 30 VOLUME 
$225,606
Company detail
CEO: Hamid Erfanian
Region: US
Website: enzo.com
Employees: 520
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

Enzo Biochem, Inc. researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally.

Recent news